Myriad Genetics (MYGN)
NASDAQ:MYGN
Holding MYGN?
Track your performance easily

Myriad Genetics (MYGN) Financial Statements

357 Followers

Myriad Genetics Financial Overview

Myriad Genetics's market cap is currently ―. The company's EPS TTM is $-1.805; its P/E ratio is -9.97; Myriad Genetics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 211.50M$ 202.20M$ 196.60M$ 191.90M$ 183.50M
Gross Profit$ 147.10M$ 137.60M$ 135.00M$ 134.30M$ 125.70M
EBIT$ -37.20M$ -25.40M-$ -60.20M$ -115.60M
EBITDA$ -20.00M$ -7.40M-$ -43.30M$ -99.40M
Net Income Common Stockholders$ -35.90M$ -26.00M$ -31.20M$ -61.30M$ -116.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 97.30M$ 104.30M$ 140.90M$ 86.30M$ 121.60M
Total Assets$ 1.09B$ 1.11B$ 1.15B$ 1.15B$ 1.19B
Total Debt$ 143.30M$ 146.80M$ 152.10M$ 201.40M$ 203.80M
Net Debt$ 46.00M$ 42.50M$ 11.20M$ 115.10M$ 82.20M
Total Liabilities$ 344.60M$ 350.50M$ 363.30M$ 465.70M$ 452.00M
Stockholders Equity$ 740.50M$ 760.00M$ 783.20M$ 683.40M$ 735.20M
Cash Flow-
Free Cash Flow$ -2.60M$ -25.30M-$ -33.00M$ -36.00M
Operating Cash Flow$ 2.60M$ -18.60M$ -54.70M$ -22.10M$ -17.20M
Investing Cash Flow$ -6.40M$ -7.10M$ -12.00M$ -2.50M$ 28.10M
Financing Cash Flow$ 2.40M$ -8.80M$ 121.90M$ -2.50M$ 38.40M
Currency in USD

Myriad Genetics Earnings and Revenue History

Myriad Genetics Debt to Assets

Myriad Genetics Cash Flow

Myriad Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis